NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ)
$0.69 -0.02 (-2.8169%)
Analysed NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ) News Sources
NeuroSense Granted Brazilian Patent Covering PrimeC Composition
06-04-2026
yahoo.com
NeuroSense Therapeutics Announces Receipt of Nasdaq Notifications Regarding Minimum Bid Price and Market Value Requirements
03-04-2026
yahoo.com
NeuroSense Therapeutics Reports Year End 2025 Financial Results and Provides Business Update
31-03-2026
yahoo.com
NeuroSense Advances Toward Key Regulatory Milestones with Strengthened Data Package and Near-Term Alzheimer's Readout
24-03-2026
yahoo.com
/C O R R E C T I O N -- NeuroSense/
18-03-2026
yahoo.com
JAMA Neurology Publishes Results from PARADIGM Phase 2b Trial of PrimeC in ALS Demonstrating Meaningful Clinical Outcomes and Biological Activity
16-03-2026
yahoo.com
PrimeC Long-Term Survival Data to Be Presented at a Leading ALS Scientific Conference
09-03-2026
yahoo.com
NeuroSense Announces Statistically Significant 65% Reduction in Risk of Death and Greater than 14-Month Median Survival Benefit with PrimeC in ALS
18-02-2026
yahoo.com
NeuroSense Expands Global IP Protection Strategy With Granted Australian Patent Covering PrimeC Composition
09-02-2026
yahoo.com
NeuroSense Granted U.S. Patent for Treatment of Alzheimer's Disease
21-01-2026
yahoo.com
What is the current price of NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ)?
The current price of NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ) is $0.69.
NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ) absolute price change since previous trading day?
The absolute price change of NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ) since the previous trading day is $-0.02.
NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ) percentage price change since previous trading day?
The percentage price change of NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ) since the previous trading day is -2.8169%.
What is the most recent average sentiment score for NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ)?
The most recent average sentiment score for NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ) is 84 out of 100.
What is the most recent average sentiment for NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ)?
The most recent sentiment for NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ) is .
SEC-8K** Filing Available For NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.